- $4.33bn
- $3.95bn
- 29
- 13
- 89
- 39
Annual balance sheet for Biohaven, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 82.5 | 76.1 | 465 | 382 |
| Net Total Receivables | — | — | 46.1 | 13.6 |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 89.8 | 94.8 | 587 | 442 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 7.58 | 13 | 52.4 | 48.6 |
| Net Goodwill | ||||
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Other Long Term Assets | ||||
| Total Assets | 111 | 142 | 662 | 513 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 29.9 | 41.9 | 90 | 55.4 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Minority Interest | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 94.7 | 107 | 123 | 85.2 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 16.8 | 34.7 | 539 | 428 |
| Total Liabilities & Shareholders' Equity | 111 | 142 | 662 | 513 |
| Total Common Shares Outstanding |